| アブストラクト | Macular degeneration is a leading cause of irreversible vision loss, significantly impacting quality of life. To enhance clinical practice and reduce the risk of drug-related macular degeneration, we analyzed drug-related trends using real-world data. Disproportionality analysis of adverse event reports from the FDA Adverse Event Reporting System (FAERS, 2004-2023) identified 67,683 cases involving 1402 drugs. Among these, 42 drugs were linked to significant risks, including treatments for breast cancer (tamoxifen, raloxifene, anastrozole, letrozole) and diabetes (insulin lispro, insulin human). The BCPNN algorithm revealed that 45.2% (19/42) of these drugs had the strongest associations with macular degeneration, with pentosan polysulfate sodium, travoprost, and tolterodine being the highest-risk drugs. Lifitegrast, nicotine, and travoprost were associated with the shortest onset times for ocular adverse events. Among drug classes, glucocorticosteroids were linked to the most rapid onset of ocular side effects (P < 0.001), typically occurring within two months compared to other drugs. Drug-related macular degeneration was more common in women (70.4%) and predominantly affected those aged 60-80. The incidence of drug-related macular degeneration has steadily increased in recent years. This study offers valuable pharmacovigilance insights, highlighting drugs and demographic factors linked to macular degeneration. |
|---|
| ジャーナル名 | Scientific reports |
|---|
| Pubmed追加日 | 2025/1/8 |
|---|
| 投稿者 | Chen, Xiaodong; Wu, Shinan; Wang, Shaopan; Yu, Chaofeng; Guo, Zihan; Huang, Shiya; Cai, Peixin; Miao, Yanliang; Li, Shiying; Chen, Qian |
|---|
| 組織名 | Xiamen University Affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory;of Ophthalmology and Visual Science, Fujian Engineering and Research Center of;Eye Regenerative Medicine, Eye Institute of Xiamen University, School of;Medicine, Xiamen University, Xiamen, 361102, Fujian, China.;Department of Ophthalmology, The First Affiliated Hospital of Xiamen University,;Xiamen, 361003, Fujian, China. shiying_li@126.com.;Medicine, Xiamen University, Xiamen, 361102, Fujian, China. qchen2@xmu.edu.cn.;Department of Ophthalmology, Xiang'an Hospital of Xiamen University, Xiamen,;361101, Fujian, China. qchen2@xmu.edu.cn. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/39774257/ |
|---|
